Dual-responsive nanovaccine for cytosolic delivery of antigens to boost cellular immune responses and cancer immunotherapy

Cancer vaccine contributing to the success of the treatment and prevention of tumors has attracted a huge attention as a strategy for tumor immunotherapy in recent years. A major challenge of cancer vaccine is to target cytosols of dendritic cells (DCs) in the lymph nodes (LNs) to enhance efficiency...

Descripción completa

Detalles Bibliográficos
Autores principales: Sui, Yang, Li, Ji, Qu, Jiqiang, Fang, Ting, Zhang, Hongyan, Zhang, Jian, Wang, Zheran, Xia, Mingyu, Dai, Yinghui, Wang, Dongkai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shenyang Pharmaceutical University 2022
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459061/
https://www.ncbi.nlm.nih.gov/pubmed/36101894
http://dx.doi.org/10.1016/j.ajps.2022.05.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459061/
https://www.ncbi.nlm.nih.gov/pubmed/36101894
http://dx.doi.org/10.1016/j.ajps.2022.05.004

Ejemplares similares